Cemiar Competitors

We deliver actionable, objective business and technology insights. Our expert guidance and tools enable faster, smarter decisions and stronger performance on an organization’s mission-critical priorities. Our unrivaled combination of business and technology insights steers clients toward the right decisions on the issues that matter most. As a $6.5 billion company, with over 20,000 associates, and a member of the S&P 500, we are an objective partner with 13,000+ client enterprises in ~90 countries and territories — across every major function, geography, industry and market sector — and boast 45+ years of experience providing insights and expert guidance to client enterprises worldwide. To learn more about how we guide the leaders who shape the world, visit gartner.com. Gartner, Inc. (NYSE: IT) Community guidelines: https://gtnr.it/3tceMrU Hot Topics Across the C-Suite LinkedIn Newsletter: https://gtnr.it/4c56S97

IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI™, advanced analytics, the latest technologies and extensive domain expertise. With approximately 88,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide. IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific progress, in an effort to advance healthcare. To learn more, visit www.iqvia.com.

S&P Global Inc. provides independent ratings, benchmarks, analytics, and data to the capital and commodity markets worldwide. It operates through three segments: Ratings, Market and Commodities Intelligence, and S&P Dow Jones Indices. The Ratings segment provides credit ratings, research and analytics, information, and benchmarks to the investors, issuers, and other market participants. The Market and Commodities Intelligence segment offers multi-asset-class data; and research and analytical capabilities, which integrate cross-asset analytics and desktop services, and deliver access to information, data, analytic services, and pricing and quality benchmarks to its customers in the commodity and energy markets. The S&P Dow Jones Indices segment provides index that maintains various valuation and index benchmarks for investment advisors, wealth managers, and institutional investors. The company was formerly known as McGraw Hill Financial, Inc. and changed its name to S&P Global Inc. in April 2016. S&P Global Inc. was founded in 1888 and is headquartered in New York.